| Literature DB >> 30548853 |
Ling Bi1, Chanlu Xie2,3,4, Mu Yao3,4, Su Su Thae Hnit2, Soma Vignarajan3, Yilun Wang3,4, Qian Wang5,6, Zhichao Xi7,8, Hongxi Xu7,8, Zhong Li9, Paul de Souza10, Andrew Tee11,12, Matthew Wong11,12, Tao Liu11,12, Xiaodong Zhao13, Jia Zhou1, Ling Xu1, Qihan Dong2,3,4.
Abstract
Cancer cell repopulation through cell cycle re-entry by quiescent (G0 ) cell is thought to be an important mechanism behind treatment failure and cancer recurrence. Facilitates Chromatin Transcription (FACT) is involved in DNA repair, replication and transcription by eviction of histones or loosening their contact with DNA. While FACT expression is known to be high in a range of cancers, the biological significance of the aberrant increase is not clear. We found that in prostate and lung cancer cells FACT mRNA and protein levels were low at G0 compared to the proliferating state but replenished upon cell cycle re-entry. Silencing of FACT with Dox-inducible shRNA hindered cell cycle re-entry by G0 cancer cells, which could be rescued by ectopic expression of FACT. An increase in SKP2, c-MYC and PIRH2 and a decrease in p27 protein levels seen upon cell cycle re-entry were prevented or diminished when FACT was silenced. Further, using mVenus-p27K- infected cancer cells to measure p27 degradation capacity, we confirm that inhibition of FACT at release from quiescence suppressed the p27 degradation capacity resulting in an increased mVenus-p27K- signal. In conclusion, FACT plays an important role in promoting the transition from G0 to the proliferative state and can be a potential therapeutic target to prevent prostate and lung cancer from progression and recurrence.Entities:
Keywords: G0; MYC; SKP2; SPT16; SSRP1
Mesh:
Substances:
Year: 2018 PMID: 30548853 DOI: 10.1002/ijc.32065
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396